Agios Pharmaceuticals, Inc. (AGIO) Backed by TD Cowen for Mitapivat’s Market Potential - Yahoo Finance
20 hours ago • Google News
Agios Pharm (AGIO)
US$ 35.224.36%
Price Chart
Key Statistics
Market Cap
$ 2.07B
P/E Ratio
3.10
Revenue (TTM)
$ 37.04M
Volume
1.01M
52W High
$ 62.58
52W Low
$ 23.41
Dividend Yield
0.00%
Beta
0.73
Technicals
50-Day MA
30.0036
200-Day MA
38.0477
52 Week High
62.58
52 Week Low
23.415
About AGIO
Agios Pharmaceuticals, Inc., a biopharmaceutical company, discovers and develops medicines in the field of cellular metabolism in the United States.
Employees
486
Headquarters
Cambridge, MA
CEO
Mr. Brian M. Goff M.B.A.
Latest News
H.C. Wainwright Maintains a Buy Rating on Agios Pharmaceuticals (AGIO), Reduces PT - MSN
16 hours ago • Google News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg